ClinicalTrials.Veeva

Menu
H

Hospital Quironsalud Barcelona | Internal Medicine Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

INCB099280
Leucovorin
KBP-5074
Triglycerides
Capecitabine
Tesetaxel
Netarsudil
Latanoprost
5-fluorouracil
Pemafibrate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 17 total trials

A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

The purpose of this study is to evaluate the safety and tolerability of INCB099280 in combination with adagrasib and to establish the MTD or identify...

Active, not recruiting
Advanced Solid Tumors
Drug: adagrasib
Drug: INCB099280

This study is being conducted to evaluate the safety and tolerability of INCB099280 in combination with axitinib and to assess the antitumor activity...

Active, not recruiting
Advanced Solid Tumors
Drug: axitinib
Drug: INCB099280

The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for ca...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their cancer:* cannot b...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

This Phase 3, randomized, Double-blind, placebo-controlled, 2-arm, parallel-group, multicenter study with randomized withdrawal will evaluate the eff...

Active, not recruiting
Chronic Kidney Diseases
Drug: KBP-5074
Drug: Placebo

A Phase 1 Dose Escalation and Expanded Cohort Study Of PF-06821497 (Mevrometostat) in Adult Patients With Relapsed/Refractory Small Cell Lung Cancer...

Enrolling
Follicular Lymphoma (FL)
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Drug: Enzalutamide
Drug: Mervometostat (PF-06821497)

This is a multicenter, open-label, single-arm study to investigate the safety, tolerability, PK, pharmacodynamics and preliminary activity of INCA324...

Enrolling
Advanced Malignancies
Drug: INCA32459-101

The goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of magrolimab in combination with docetaxel in...

Active, not recruiting
Solid Tumor
Drug: Magrolimab
Drug: Docetaxel

The main purpose of the study is to evaluate safety and efficacy of taletrectinib (also known as AB-106 or DS-6051b) monotherapy in the treatment of...

Enrolling
Non Small Cell Lung Cancer
Drug: Taletrectinib

This study will compare DS-8201a to physician choice standard treatment.Participants must have HER2-low breast cancer that has been treated before.Pa...

Active, not recruiting
Breast Cancer
Drug: Eribulin
Drug: Capecitabine

Trial sponsors

Incyte logo
Daiichi Sankyo logo
Aerie Pharmaceuticals logo
A
Gilead Sciences logo
H
Ipsen logo
K
Kowa logo
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems